GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
South Korea flag South Korea · Delayed Price · Currency is KRW
20,450
+300 (1.49%)
Feb 10, 2025, 2:34 PM KST

GemVax&KAEL Revenue

GemVax&KAEL had revenue of 12.74B KRW in the quarter ending September 30, 2024, a decrease of -6.23%. This brings the company's revenue in the last twelve months to 62.73B, down -8.77% year-over-year. In the year 2023, GemVax&KAEL had annual revenue of 72.21B, down -4.74%.

Revenue (ttm)
62.73B
Revenue Growth
-8.77%
P/S Ratio
20.48
Revenue / Employee
337.27M
Employees
186
Market Cap
1,289.60B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202372.21B-3.60B-4.74%
Dec 31, 202275.80B15.43B25.56%
Dec 31, 202160.37B-5.29B-8.06%
Dec 31, 202065.66B23.00B53.91%
Dec 31, 201942.66B-4.58B-9.69%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 300.87T
SK hynix 57.73T
LG Energy Solution 25.62T
Samsung Biologics 4,364.39B
Hyundai Motor Company 170.28T
Celltrion 2,876.25B
Kia Corporation 104.63T
NAVER 10.39T
Revenue Rankings